Bridge loan

Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG

Retrieved on: 
Wednesday, April 3, 2024

KARL STORZ has communicated that the proposed purchase price represents its “best and final” offer to the Company.

Key Points: 
  • KARL STORZ has communicated that the proposed purchase price represents its “best and final” offer to the Company.
  • During the exclusivity period, KARL STORZ will be conducting diligence and the parties will be negotiating a definitive merger agreement.
  • In conjunction with the letter of intent, Asensus has entered into a fully secured Promissory Note (the “Bridge Loan”) with KARL STORZ.
  • Asensus and KARL STORZ plan to work diligently during the exclusivity period to negotiate and finalize a definitive merger agreement.

SciSparc Advances the Acquisition Process of a Leading Vehicle Importer Company in Israel with the provision of a Bridge Loan of $1.4 million

Retrieved on: 
Friday, January 19, 2024

With this Bridge Loan, SciSparc continues to proceed towards the Acquisition, pursuant to the LOI and the additional negotiated terms between the Company and the Target Company, announced on November 22 and December 7, 2023, respectively.

Key Points: 
  • With this Bridge Loan, SciSparc continues to proceed towards the Acquisition, pursuant to the LOI and the additional negotiated terms between the Company and the Target Company, announced on November 22 and December 7, 2023, respectively.
  • As previously announced on December 7, 2023, the Company intends to acquire 100% of the Target Company and will establish a new wholly-owned Israeli subsidiary, which would in turn merge with and into the Target Company.
  • Following the Acquisition closing (the”Closing”), it is contemplated that shareholders of the Company will hold approximately 50.01% of the share capital of the resulting combined company.
  • The Bridge Loan amount, together with any accrued interest (the “Owed Amount”), may be repaid in part or in whole at the discretion of the Target Company prior to the repayment date.

Appili Therapeutics Announces Issuance of Patent for ATI-1701 Biodefense Vaccine Candidate to Protect Against Tularemia and Provides Update on Bridge Loan

Retrieved on: 
Friday, December 15, 2023

16/982,322 filed on September 18, 2020 and titled “A Method for Lyophilizing Live Vaccine Strains of Francisella Tularensis”.

Key Points: 
  • 16/982,322 filed on September 18, 2020 and titled “A Method for Lyophilizing Live Vaccine Strains of Francisella Tularensis”.
  • The patent covers the composition and preparation methods for the vaccine through 2039.
  • Appili licensed the biodefense vaccine candidate ATI-1701 from NRC in December 2017.
  • Under the amended terms, the Bridge Loan will now mature on March 31, 2024, subject to acceleration in connection with certain corporate events.

NUBURU Announces $5.5 Million Bridge Financing

Retrieved on: 
Tuesday, November 14, 2023

NUBURU, Inc. (“NUBURU” or the “Company”) (NYSE American: BURU), a leading innovator in high-power and high-brightness industrial blue laser technology, today announced it has entered into a secured bridge loan agreement (the “Bridge Loan” or “Bridge Financing”) with existing investors and a new institutional investor.

Key Points: 
  • NUBURU, Inc. (“NUBURU” or the “Company”) (NYSE American: BURU), a leading innovator in high-power and high-brightness industrial blue laser technology, today announced it has entered into a secured bridge loan agreement (the “Bridge Loan” or “Bridge Financing”) with existing investors and a new institutional investor.
  • The Bridge Financing with a principal amount of $5.5 million is intended to finance the Company until it secures long-term credit financing, which is anticipated in the near term.
  • Brian Knaley, CEO of NUBURU, commented: “I want to thank our existing and newly participating investors for their trust and commitment.
  • Northland Capital Markets acted as sole placement agent on the institutional investor portion of the Bridge Financing.

Doc2Doc Lending Ramps Up Growth and Expansion for the Rest of 2023

Retrieved on: 
Tuesday, August 8, 2023

ATLANTA, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Doc2Doc Lending , a personal lending platform designed specifically to meet the unique needs of physicians and dentists, today announced the results of its capital funding initiative and a robust growth trajectory for the back half of the year.

Key Points: 
  • ATLANTA, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Doc2Doc Lending , a personal lending platform designed specifically to meet the unique needs of physicians and dentists, today announced the results of its capital funding initiative and a robust growth trajectory for the back half of the year.
  • The company reported raising more than $35 million in debt and equity capital to support its strategic expansion.
  • Founded by doctors, Doc2Doc focuses on providing financial solutions that empower physicians and dentists to achieve their goals — from relocating for a residency to consolidating high-interest credit card debt to fulfilling their dreams by building their own practices.
  • “We are thrilled to work with Doc2Doc and empower doctors to pursue their goals with financial products built for them,” said Jason Hardgrave, CEO, DR Bank.

Sandfire Resources America Announces Variation to Bridge Loan Agreement

Retrieved on: 
Saturday, July 1, 2023

WHITE SULPHUR SPRINGS, Mont., June 30, 2023 (GLOBE NEWSWIRE) -- Sandfire Resources America Inc. ("Sandfire America" or the "Company") announces that it has entered into a second variation agreement (the "Second Variation") to its bridge loan agreement, as amended (the “Bridge Loan”) with Sandfire BC Holdings (Australia) Pty Ltd. ("Sandfire BC"), the Company's largest shareholder, and Tintina Montana Inc., a wholly-owned subsidiary of the Company ("Tintina Montana").

Key Points: 
  • WHITE SULPHUR SPRINGS, Mont., June 30, 2023 (GLOBE NEWSWIRE) -- Sandfire Resources America Inc. ("Sandfire America" or the "Company") announces that it has entered into a second variation agreement (the "Second Variation") to its bridge loan agreement, as amended (the “Bridge Loan”) with Sandfire BC Holdings (Australia) Pty Ltd. ("Sandfire BC"), the Company's largest shareholder, and Tintina Montana Inc., a wholly-owned subsidiary of the Company ("Tintina Montana").
  • Pursuant to the Second Variation, the amount available to be borrowed under the Second Variation, Variation and Bridge Loan will be increased from an aggregate of up to US$22.0 million to an aggregate of up to US$32.0 million through one or more advances, and the latest maturity will be extended from June 30, 2023 to June 30, 2024, subject to the terms of the Second Variation and the Bridge Loan.
  • All other terms and conditions of the Bridge Loan shall remain in full force and effect, except as amended by the Second Variation.
  • No securities of the Company are issuable under the Agreement.

Robex Announces Its Results for the First Quarter of Fiscal Year 2023

Retrieved on: 
Tuesday, May 30, 2023

This line of credit bears interest at an annual rate of 8% and will mature on April 3, 2024.

Key Points: 
  • This line of credit bears interest at an annual rate of 8% and will mature on April 3, 2024.
  • Short-form base shelf prospectus: On May 16, 2023, the Autorité des marchés financiers issued a receipt for the preliminary short-form base shelf prospectus dated May 15, 2023 (the “Preliminary Shelf Prospectus”).
  • Notwithstanding the foregoing, there can be no assurance that the Robex securities will be offered or sold during this 25-month period.
  • Robex will be holding a telephone conference to discuss the results of the first quarter of fiscal year 2023 during a live webcast organized by Renmark Financial on Wednesday, June 7, 2023 at 10:00 a.m., EDT – New York.

Bunker Hill Announces Upsized and Improved $67 Million Financing Package to Enable Completion of the Mine Restart, Offtake Agreement

Retrieved on: 
Tuesday, May 23, 2023

TORONTO, May 23, 2023 (GLOBE NEWSWIRE) -- Bunker Hill Mining Corp. (CSE: BNKR) (“Bunker Hill” or the “Company) is pleased to announce the execution of a non-binding term sheet outlining an upsized and improved $67 million non-dilutive project finance package with Sprott Private Resource Streaming & Royalty Corp (“Sprott Streaming”). All figures in this news release are in US dollars unless otherwise stated.

Key Points: 
  • Sam Ash, CEO, stated “We are excited to announce an upsized and improved project finance package that we expect to backstop the full financing of the Bunker Hill mine restart, materially strengthen our balance sheet and liquidity, and support our TSX-V application.
  • We are thrilled to have partnered with Sprott Streaming, who have demonstrated their commitment and support for the project each step of the way.
  • Including the previously funded $8 million Royalty Convertible Debenture, $6 million Series 1 Convertible Debenture (the “CD1”), and $15 million Series 2 Convertible Debenture (the “CD2”), Sprott Streaming’s total commitment to the Bunker Hill Mine restart would increase to $96 million.
  • Any agreement with a metal trader, in lieu of the Debt Facility, would be subject to approval by Teck and Sprott Streaming.

Cardlytics Announces Update to Bridg Earnout Payments

Retrieved on: 
Monday, May 1, 2023

ATLANTA, May 01, 2023 (GLOBE NEWSWIRE) -- Cardlytics (NASDAQ: CDLX), an advertising platform in banks’ digital channels, announced today a determination of the First Anniversary Payment Amount in relation to the acquisition of Bridg.

Key Points: 
  • ATLANTA, May 01, 2023 (GLOBE NEWSWIRE) -- Cardlytics (NASDAQ: CDLX), an advertising platform in banks’ digital channels, announced today a determination of the First Anniversary Payment Amount in relation to the acquisition of Bridg.
  • Additionally, because of the Independent Accountant’s determination, Cardlytics anticipates the Second Anniversary Payment Amount due under the merger agreement to be $0, inclusive of brokerage fees and transaction bonuses and accounting for all true-ups and credits.
  • Cardlytics anticipates the remaining consideration for both earnouts will be paid with 3.4 million shares of Cardlytics common stock, which significantly decreases investor dilution as compared to Cardlytics’ previous publicly disclosed estimates.
  • “We are pleased to reach a conclusion in the Independent Accountant proceeding that gives us clear visibility into the total amount of both earnout payments, which are collectively in line with the expectations we set out on our most recent earnings call.

Robex publishes its results for the fourth quarter and for fiscal year 2022

Retrieved on: 
Monday, May 1, 2023

For the twelve-month period ended December 31, 2022, production reached 46,651 ounces, stable (+0.2%) as opposed to the comparable period in 2021.

Key Points: 
  • For the twelve-month period ended December 31, 2022, production reached 46,651 ounces, stable (+0.2%) as opposed to the comparable period in 2021.
  • The year 2022 was more difficult than the previous years, resulting in production slightly below management’s estimate of 50,000 ounces.
  • Reverse circulation (RC) and diamond drilling started at the beginning of 2022, the objective being to increase resources.
  • Robex will present its results for the fourth quarter and for fiscal year 2022 during a live webcast organized by Renmark Financial on May 2, 2023 at 9:00 a.m., EDT.